These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20619393

  • 1. Association of dyslipidemia in moderate to severe meibomian gland dysfunction.
    Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW.
    Am J Ophthalmol; 2010 Sep; 150(3):371-375.e1. PubMed ID: 20619393
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS, Howard MK, Singh JS.
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H, Kamal-Bahl S, Wong ND.
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [Abstract] [Full Text] [Related]

  • 4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 5. Meibomian gland dysfunction and hypercholesterolemia.
    Pinna A, Blasetti F, Zinellu A, Carru C, Solinas G.
    Ophthalmology; 2013 Dec; 120(12):2385-2389. PubMed ID: 23747164
    [Abstract] [Full Text] [Related]

  • 6. Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population.
    Guliani BP, Bhalla A, Naik MP.
    Indian J Ophthalmol; 2018 Oct; 66(10):1411-1416. PubMed ID: 30249824
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators.
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [Abstract] [Full Text] [Related]

  • 8. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA, Koro CE, Chan W, Bowlin SJ, Sprecher DL.
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA, Chilmeran SK.
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [Abstract] [Full Text] [Related]

  • 10. Dyslipidemia and its Association with Meibomian Gland Dysfunction: A Systematic Review.
    Kuriakose RK, Braich PS.
    Int Ophthalmol; 2018 Aug; 38(4):1809-1816. PubMed ID: 28688025
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M, Bilińska ZT, Mazurkiewicz Ł, Grzybowski J, Kruk M, Kurjata P, Piotrowski W, Ruzyłło W.
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
    Goldberg AC, Bittner V, Pepine CJ, Kelly MT, Thakker K, Setze CM, Lele A, Sleep DJ.
    Am J Cardiol; 2011 Mar 15; 107(6):898-905. PubMed ID: 21247520
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul 15; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between serum lipid level and meibomian gland dysfunction subtype in Korea using propensity score matching.
    Ha M, Song J, Park S, Han K, Hwang HS, Kim HS, Arita R, Na KS.
    Sci Rep; 2021 Aug 09; 11(1):16102. PubMed ID: 34373581
    [Abstract] [Full Text] [Related]

  • 20. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
    Cobain MR, Pencina MJ, D'Agostino RB, Vasan RS.
    Am J Med; 2007 Jul 09; 120(7):623-30. PubMed ID: 17602937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.